• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • Countering AMR
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Limitations of CBO’s Simulation Model of New Drug Development as a Tool for PolicymakersRead more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes
  • PhRMA

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
When Generic Measures Fail to Reflect What Matters to Patients: Three Case StudiesRead more
© NCI/Unsplash
  • Health Technology Assessment…
  • Measuring and Valuing Outcomes
  • Canada

Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies

Cancer_WellcomeCollection_landscape
Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic TherapiesRead more
© WellcomeCollection
Close
OHE
  • All Publications

    Filter by:
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • Countering AMR
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 19th July 2022

OHE is Leading Research to Develop an EQ-5D ‘Bolt-on’ for Hearing

OHE and the University of Technology Sydney are leading a study funded by the EuroQol Research Foundation to develop a ‘bolt-on’ descriptor for the EQ-5D. The goal is to develop and test new questions that can be used with people…

Sian 2
Sian Besley
Share:

OHE and the University of Technology Sydney are leading a study funded by the EuroQol Research Foundation to develop a ‘bolt-on’ descriptor for the EQ-5D. The goal is to develop and test new questions that can be used with people who have hearing impairments. We’re currently seeking research participants.

The EQ-5D descriptive system forms the basis of a questionnaire that is widely used in health research. In particular, the EQ-5D is used to estimate quality-adjusted life years (QALYs), which are the cornerstone of value in health technology assessment in the UK and elsewhere. However, in certain circumstances, the EQ-5D has been shown to perform less well than other measures of health outcome. In particular, the EQ-5D sometimes does not detect meaningful changes in hearing. This has led some researchers to call for the development of ‘bolt-on’ items, which would be additional aspects of health added to the core set of five EQ-5D domains (mobility, self-care, usual activities, pain/discomfort, anxiety/depression). The EuroQol Group is keen to explore the development of bolt-ons, though it is not committed to expanding the EQ-5D at this stage.

In collaboration with the University of Technology Sydney, the University of Oxford, and Maths in Health, we have been funded by the EuroQol Research Foundation to develop bolt-on descriptors for hearing. Researchers are increasingly recognising the need for health outcome measurement to be patient-centred, which means that the development of new measures should be informed by the views of people who will ultimately be asked to complete the questionnaires. To this end, our work will employ both qualitative and quantitative research methods to develop candidate bolt-ons. The project is organised into three phases.

Phase 1: Development of descriptors

In the first part of the study, we will generate a set of possible descriptors that might make for suitable bolt-on items. One input to this process is a systematic literature review of qualitative evidence, ensuring we make the most of previous research on the impact of hearing on people’s quality of life. Following the review, we will conduct a series of online discussion groups to better understand lived experiences of hearing impairments. Through this, we aim to ensure that the resulting bolt-on captures aspects of health that are considered most relevant in a way that is meaningful to people completing the measures. The groundwork of the literature review will guide a set of discussion groups, which we will be conducting in the UK in the form of online discussion forums and a video focus group for British Sign Language (BSL) users. Participants will have varying degrees of impairment and will be asked to discuss the ways in which hearing impairment affects their quality of life and how they would describe that.

Phase 2: Qualitative testing

Based on the findings from Phase 1, we’ll conduct a series of interviews with people who have lived experience of hearing impairment. We’ll ask participants to complete EQ-5D-5L questionnaires with candidate bolt-on descriptors, followed by cognitive debriefing. This will help us to understand potential difficulties with comprehensibility or accessibility.

Phase 3: Quantitative testing

Once we have a set of possible bolt-on descriptors, they will be subject to psychometric testing. This will involve a cross-sectional survey conducted online, which will ask participants to complete the EQ-5D-5L questionnaire with candidate bolt-on items and other condition-specific instruments. The analysis will include descriptive analysis, classical psychometric analysis, convergent and discriminant validity, factor analysis, and regressions. Item response theory and Rasch analysis will also be used to compare the performance of candidate hearing bolt-on items. 

Get involved

We are currently conducting Phase 1 of the study and are looking for participants to take part in online discussion groups and interviews. If you have experienced hearing impairment, are over 18 and live in the UK, please consider volunteering your time to our research. To sign up to participate, please complete the forms on our project website, where you will also find BSL versions of our recruitment information.

If you are a researcher, you can follow the progress of our project on ResearchGate.

For more information about the study, please visit our website or contact the project team here.

Related research

Mulhern, B.J., Sampson, C., Haywood, P., Addo, R., Page, K., Mott, D., Shah, K., Janssen, M.F. and Herdman, M., 2022. Criteria for developing, assessing and selecting candidate EQ-5D bolt-ons. Quality of Life Research. 10.1007/s11136-022-03138-7.

Sampson, C., Addo, R., Haywood, P., Herdman, M., Janssen, B., Mulhern, B., Page, K., Reardon, O., Sanchez, M.R., Schneider, J., and others, 2019. PMU141 Development of EQ-5D-5L Bolt-ons for Cognition and Vision. Value in Health, 22, p.S733. 10.1016/j.jval.2019.09.1759.

 

  • EQ-5D and PROMs
  • Measuring and Valuing Outcomes
  • News Releases

Related News

  • News
  • October 2021

We have launched OHE Bulletin, a new monthly newsletter

Read more
Danzon_Patricia_1305 (1)
  • News
  • June 2020

Victor R. Fuchs Award for 2020 Goes to Patricia Danzon

Read more
  • News
  • March 2020

Economists – Research and Consultancy

Read more
  • News
  • October 2019

Press Release: Proposed International Price Index Effectively Outsources Pharmaceutical Policy Decisions to Other Countries

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!